Home
Resources
Product Analysis
Acknowledgements
About
Home
References
Biotech components
Biotech components
Gene Editing
Products 1 to 10 of 33
Modify Display Properties
Biotech components
Business models
Country of production
Country of distribution
Intended consumer
Date added
Date last modified
Known funding amount
Funding types
Industry
Market status
Organization
Organization type(s)
Product categories
Production process
Source
Trading symbol
Value chain stage
Sort: Title (A-Z)
Date added (oldest-newest)
Date added (newest-oldest)
Date modified (oldest-newest)
Date modified (newest-oldest)
Title (A-Z)
Title (Z-A)
Organization (A-Z)
Organization (Z-A)
Bio-DEM™
by
Lygos, Inc (Advanced Biofuels Process Demonstration Unit)
Biotech components:
Enzyme
+
Gene Editing
+
Microbe
+
Plant
Business models:
B2B
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2019/09/12 14:33 (5 years ago)
Date last modified:
2019/09/12 14:33 (5 years ago)
Known funding amount:
N/A
Funding types:
Shareholder Investment
+
Venture Capital
Industry:
Industrial
+
Multipurpose
Market status:
On the market
Organization type(s):
Private Company
Product categories:
Additive
+
Chemical
Production process:
N/A
Source:
Web search
Trading symbol:
N/A
Value chain stage:
Input
Biodata Tools/Medicine
by
Girihlet
Biotech components:
Gene Editing
Business models:
B2B
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Research
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/09/28 16:57 (6 years ago)
Known funding amount:
250,000 USD
Funding types:
Private Funding
Industry:
Health
Market status:
Under Development
Organization type(s):
Private Company
Product categories:
Medical Treatment
Production process:
Closed Production
Source:
NASEM Database
Trading symbol:
N/A
Value chain stage:
Input
Bioengineered mRNA for gene therapy
by
University of Wisconin-Madison
Biotech components:
Gene Editing
Business models:
B2B
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2020/12/18 14:36 (4 years ago)
Date last modified:
2020/12/18 14:36 (4 years ago)
Known funding amount:
N/A
Funding types:
University
Industry:
Medical
Market status:
Early Stage Concept
Organization type(s):
University
Product categories:
N/A
Production process:
N/A
Source:
Web search
Trading symbol:
N/A
Value chain stage:
Platform
Cellular Implant for Detection of Hypercalcemia Associated with Cancer
by
ETH Zurich
Biotech components:
Gene Editing
Business models:
B2C
Country of production:
Switzerland
Country of distribution:
Switzerland
Intended consumer:
Consumer
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/10/08 14:47 (6 years ago)
Known funding amount:
N/A
Funding types:
Government
Industry:
Health
Market status:
Early Stage Concept
Organization type(s):
Research Institution
+
University
Product categories:
Medical Treatment
Production process:
Closed Production
Source:
Web search
Trading symbol:
N/A
Value chain stage:
Finished Product
CRISPR/Cas9 Application in Poplar Trees
by
VIB (the Flanders Institute for Biotechnology)
Biotech components:
Gene Editing
Business models:
B2B
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2020/12/18 14:35 (4 years ago)
Date last modified:
2020/12/18 14:35 (4 years ago)
Known funding amount:
N/A
Funding types:
N/A
Industry:
Industrial
Market status:
Early Stage Concept
+
More information needed
Organization type(s):
Research Institution
Product categories:
Construction
+
Chemical
Production process:
N/A
Source:
Web search
Trading symbol:
N/A
Value chain stage:
Input
+
Platform
crPhage
by
Locus Biosciences
Biotech components:
Gene Editing
+
Molecule
+
Virus
Business models:
B2C
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2019/09/12 15:10 (5 years ago)
Date last modified:
2019/09/12 15:10 (5 years ago)
Known funding amount:
N/A
Funding types:
Private Funding
+
Shareholder Investment
Industry:
Health
+
Medical
Market status:
Under Development
Organization type(s):
Public Company
Product categories:
Medical Treatment
+
Medicine
Production process:
N/A
Source:
Web search
Trading symbol:
N/A
Value chain stage:
Finished Product
Drought Resistant GM Wheat
by
Bioceres
Biotech components:
Gene Editing
+
Plant
Business models:
B2B
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2020/12/18 14:38 (4 years ago)
Date last modified:
2020/12/18 14:38 (4 years ago)
Known funding amount:
N/A
Funding types:
Private Funding
+
University
Industry:
Food & Agriculture
Market status:
Under Development
Organization type(s):
Private Company
Product categories:
Food
Production process:
N/A
Source:
Web search
Trading symbol:
N/A
Value chain stage:
Input
Engineered Tilapia
by
Intrexon
Biotech components:
Gene Editing
Business models:
B2C
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2019/09/12 14:57 (5 years ago)
Date last modified:
2019/09/12 14:59 (5 years ago)
Known funding amount:
N/A
Funding types:
Shareholder Investment
Industry:
Food & Agriculture
Market status:
Early Stage Concept
Organization type(s):
Public Company
Product categories:
Food
Production process:
N/A
Source:
N/A
Trading symbol:
XON
(NASDAQ)
Value chain stage:
Finished Product
Florian™ “On Demand” Flowering
by
Intrexon
Biotech components:
Gene Editing
+
Plant
Business models:
B2C
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2019/09/12 14:47 (5 years ago)
Date last modified:
2019/09/12 14:47 (5 years ago)
Known funding amount:
N/A
Funding types:
Shareholder Investment
Industry:
Food & Agriculture
+
Novelty
Market status:
Early Stage Concept
Organization type(s):
Public Company
Product categories:
Plant
Production process:
N/A
Source:
N/A
Trading symbol:
XON
(NASDAQ)
Value chain stage:
Finished Product
Friendly Mosquitoes (not Aedes)
by
Intrexon
Biotech components:
Animal
+
Gene Editing
Business models:
B2C
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2020/02/10 09:59 (5 years ago)
Date last modified:
2020/02/10 09:59 (5 years ago)
Known funding amount:
N/A
Funding types:
Shareholder Investment
Industry:
Health
Market status:
Under Development
Organization type(s):
Public Company
Product categories:
N/A
Production process:
N/A
Source:
Web search
Trading symbol:
XON
(NASDAQ)
Value chain stage:
Finished Product
1
2
3
4
Login
or
register
to add and edit products
Future
Bioengineered
Products
Home
Resources
Product Analysis
Acknowledgements
About
